Jill C. Milne

CIK 1644246 · CEO and President · last filed 2026-06-02

Jill C. Milne is a CEO and President who has filed 19 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing shows the insider was granted $11.2K of BCRX on Jun 2, 2026. Current disclosed insider exposure totals $144.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$144.8K

Companies

3

Total Filings

19

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCRX Director 16,644 $8.70 $144.8K $0 3 2026-06-02
Astria Therapeutics, Inc. (ATXS) Delisted CEO and President 0 $12.58 $0 $0 5 2026-01-23
Astria Therapeutics, Inc. (CATB) Delisted CEO and President 253,872 $8.54 $2.17M $0 11 2021-06-02

Recent Filings

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-02 BCRX Grant (A) +1,262 $11.2K EDGAR
2026-03-03 BCRX Grant (A) +528 $4.6K EDGAR
2026-01-27 BCRX Grant (A) +14,854 $0 EDGAR
2026-01-23 Astria Therapeutics, Inc. (ATXS) Delisted Disp (D) −4,377 $0 EDGAR
2025-03-25 Astria Therapeutics, Inc. (ATXS) Delisted Grant (A) $0 EDGAR
2024-02-12 Astria Therapeutics, Inc. (ATXS) Delisted Grant (A) $0 EDGAR
2023-06-06 Astria Therapeutics, Inc. (ATXS) Delisted Grant (A) $0 EDGAR
2022-03-03 Astria Therapeutics, Inc. (ATXS) Delisted Grant (A) $0 EDGAR
2021-06-02 Astria Therapeutics, Inc. (CATB) Delisted Grant (A) $0 EDGAR
2020-02-14 Astria Therapeutics, Inc. (CATB) Delisted Grant (A) $0 EDGAR
Showing 110 of 19
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.